Polanec Stephan, Helbich Thomas H, Bickel Hubert, Pinker-Domenig Katja, Georg Dietmar, Shariat Shahrokh F, Aulitzky Wolfgang, Susani Martin, Baltzer Pascal A
Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna (AKH), Waehringer-Guertel 18-20, A-1090 Wien, Austria.
Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna (AKH), Waehringer-Guertel 18-20, A-1090 Wien, Austria; Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University Vienna (AKH), Waehringer-Guertel 18-20, A-1090 Wien, Austria.
Eur J Radiol. 2016 Jun;85(6):1125-31. doi: 10.1016/j.ejrad.2016.03.025. Epub 2016 Mar 29.
To compare the reproducibility and diagnostic performance of PI-RADS version 2 (v2) and version 1 (v1) for the diagnosis of prostate cancer (PCa) on multiparametric MRI.
This IRB-approved retrospective study included 65 consecutive biopsy-naïve or biopsy-negative patients suspicious for PCa (mean age: 65 years, mean PSA: 10.8ng/ml) who were undergoing MR-guided biopsy after multiparametric 3T prostate MRI (T2w, DWI, DCE). Two independent readers (R1; R2) scored the prostate lesions according to the v2 score and the v1 sum score. Diagnostic measures (sensitivity, specificity, and area under the ROC-curve) were compared for all cases and stratified by location (transitional zone, TZ, peripheral zone, PZ). Inter-reader agreement was assessed by kappa statistics.
Inter reader agreement for v2 and v1 was substantial to almost perfect (kappa v2: 0.71, v1: 0.81). Overall, sensitivity between both readers and methods did not differ (p>0.05). Overall specificity was higher using v1 compared to v2 (R1: p=0.0078, R2: p=0.0313) In the TZ, v2 showed a higher AUC (0.81-0.84) compared to v1 (AUC 0.77-0.78). Here, the sensitivity of v2 (87.5-100%) was higher than that of v1 (75%) while v2 specificity (50%-56.3%) was lower than that of v1 (68.8-75%). In the PZ, AUCs were higher using v1 (AUC 0.82-0.83) compared to v2 (AUC 0.61-0.63). The specificity for v1 was higher (43.8-62.3%) than that for v2 (12.5-18.8%) while both v2 and v1 achieved 100% sensitivity.
PI-RADS v2 and v1 inter-reader agreement is excellent, but their diagnostic performance differs. While v2 appears to be the preferable method for the evaluation of TZ lesions, v1 performs better in the PZ.
比较PI-RADS第2版(v2)和第1版(v1)在多参数MRI上诊断前列腺癌(PCa)的可重复性和诊断性能。
这项经机构审查委员会批准的回顾性研究纳入了65例连续的初诊未活检或活检阴性但怀疑患有PCa的患者(平均年龄:65岁,平均PSA:10.8ng/ml),这些患者在接受多参数3T前列腺MRI(T2w、DWI、DCE)检查后接受了MR引导下活检。两名独立阅片者(R1;R2)根据v2评分和v1总分对前列腺病变进行评分。比较所有病例的诊断指标(敏感性、特异性和ROC曲线下面积),并按病变位置(移行区,TZ;外周区,PZ)进行分层。阅片者间的一致性通过kappa统计量进行评估。
v2和v1阅片者间的一致性为高度一致至几乎完全一致(v2的kappa值:0.71,v1的kappa值:0.81)。总体而言,两位阅片者以及两种方法之间的敏感性无差异(p>0.05)。与v2相比,v1的总体特异性更高(R1:p = 0.0078,R2:p = 0.0313)。在TZ中,v2的AUC(0.81 - 0.84)高于v1(AUC 0.77 - 0.78)。在此处,v2的敏感性(87.5% - 100%)高于v1(75%),而v2的特异性(50% - 56.3%)低于v1(68.8% - 75%)。在PZ中,v1的AUC(0.82 - 0.83)高于v2(AUC 0.61 - 0.63)。v1的特异性更高(43.8% - 62.3%),高于v2(12.5% - 18.8%);而v2和v1的敏感性均达到100%。
PI-RADS v2和v1阅片者间的一致性良好,但它们的诊断性能有所不同。虽然v2似乎是评估TZ病变的更优方法,但v1在PZ中的表现更好。